You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Details for Patent: 3,565,924


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,565,924
Title:25-hydroxycholfcalciferol
Abstract:25-HYDROXYCHOLECALCIFEROL. THE COMPOUND IS CHARACTERIZED BY VITAMIN-D-LIKE ACTIVITY AND FINDS APPLICATION AS AN ANIMAL FEED SUPPLEMENT.
Inventor(s):Hector Floyd De Luca, John Wilson Blunt
Assignee:Wisconsin Alumni Research Foundation
Application Number:US741239A
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 3,565,924

Introduction

When analyzing a U.S. patent, it is crucial to understand the scope and claims of the patent, as these elements define the intellectual property rights granted to the inventor. This article will delve into the specifics of United States Patent 3,565,924, exploring its claims, scope, and the broader patent landscape.

What is a U.S. Patent?

A U.S. patent is a grant of exclusive rights to an inventor for their invention, issued by the U.S. Patent and Trademark Office (USPTO)[1].

The Importance of Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and the rights granted to the inventor. These claims must be clear, concise, and supported by the patent's description and drawings[3].

Determining Inventorship

Before diving into the specifics of a patent, it is essential to understand who the true and only inventors are. U.S. patent law requires that only those who conceived the idea and reduced it to practice be listed as inventors[2].

United States Patent 3,565,924: Overview

To analyze the scope and claims of United States Patent 3,565,924, one must first identify the patent's title, inventors, and the date it was granted. However, since the specific details of this patent are not provided in the sources, we will discuss the general process and principles that apply.

Patent Title and Abstract

The title and abstract provide a brief overview of the invention. This information is crucial for understanding the general scope of the patent.

Claims

The claims section is where the inventor defines the boundaries of their invention. There are two types of claims:

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the independent claims.

For example, if a patent has multiple claims, the independent claims will outline the broadest scope of the invention, while dependent claims will narrow down the scope by adding additional limitations[3].

Scope of the Patent

The scope of a patent is determined by the claims. Narrower claims are generally easier to enforce but offer less protection, while broader claims offer more protection but are more challenging to enforce and may be subject to more scrutiny during the examination process[3].

Analyzing Patent Scope Metrics

Researchers have developed metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can indicate the breadth of the patent and its likelihood of being granted. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Eligibility and the Alice Test

When evaluating the claims of a patent, it is crucial to determine whether they are directed to patent-eligible subject matter. The Supreme Court's "Alice" test is a two-step process used to determine this:

  • Step One: Determine whether the claims are directed to an abstract idea.
  • Step Two: If the claims are directed to an abstract idea, determine whether they include elements that transform them into a patent-eligible application[5].

The Role of the USPTO in Patent Examination

The USPTO plays a critical role in examining patent applications to ensure that the claims are valid and enforceable. The examination process can narrow the scope of patent claims, and longer examination durations often result in more significant changes to the claims[3].

Using Global Dossier for Patent Research

For comprehensive research on a patent, tools like the Global Dossier provided by the USPTO can be invaluable. This service allows users to access file histories of related applications from participating IP offices, helping to understand the patent family and related applications[4].

Public Search Facilities

The USPTO Public Search Facility in Alexandria, VA, offers public access to patent and trademark information, which can be useful for conducting thorough searches and analyses of patents[4].

Key Takeaways

  • Clear Claims: Patent claims must be clear and concise to define the scope of the invention effectively.
  • Inventorship: Only true and only inventors should be listed on the patent application.
  • Scope Metrics: Independent claim length and count can indicate the breadth and enforceability of a patent.
  • Patent Eligibility: The "Alice" test is crucial for determining whether patent claims are directed to patent-eligible subject matter.
  • USPTO Role: The USPTO's examination process can significantly impact the final scope of a patent.

FAQs

What is the primary role of the USPTO in the patent process?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that patent applications meet the necessary legal and technical standards.

How do you determine the true and only inventors for a patent application?

Inventorship is determined by identifying who conceived the idea and reduced it to practice. Only these individuals should be listed as inventors on the patent application[2].

What are the key metrics for measuring patent scope?

Independent claim length and independent claim count are simple yet effective metrics for measuring patent scope and predicting the likelihood of a patent being granted[3].

What is the "Alice" test in patent law?

The "Alice" test is a two-step process used to determine whether patent claims are directed to patent-eligible subject matter. It involves identifying whether the claims are directed to an abstract idea and, if so, whether they include elements that transform them into a patent-eligible application[5].

How can the Global Dossier help in patent research?

The Global Dossier provides access to file histories of related applications from participating IP offices, allowing users to see the patent family, classification, and citation data for these applications, which is invaluable for comprehensive patent research[4].

Sources

  1. U.S. Patent and Trademark Office (USPTO) - USAGov
  2. Determining Inventorship for US Patent Applications
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. Search for patents - USPTO
  5. CONTOUR IP HOLDING LLC v. GOPRO, INC.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 3,565,924

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 3,565,924

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Belgium 742836 ⤷  Try for Free
Canada 931075 ⤷  Try for Free
Canada 931504 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.